← Insider buys
EWTX

Edgewise Therapeutics, Inc. · Healthcare

Chief Scientific Officer Alan J Russell sold $7.9M of Edgewise Therapeutics, Inc.

Sold$7,881,402
$39.41Price
200,000Shares
−89%Stake

What EWTX did after the filing

Filed Jul 2Copier in Jul 6
The stock from Mon, Jul 6 open, $39.39
+12.0%
S&P 500, same days
+2.5%

Measured over 30 trading days, to the Aug 18 close.

Traded Wed, Jul 1. Filed Thu, Jul 2, 5:21 PM ET, after the close. Returns use the Jul 6 open and the Aug 18 close. Not investment advice.